HOME > VC DEALS > Tubulis
Deal IconDeal

Tubulis

Tubulis raises €308 million Series C

Tubulis, a Planegg-Martinsried, Munich, Germany-based cancer drug development company, raised €308 million in a Series C fundraising round led by Venrock Healthcare Capital Partners with participation from Wellington Management, Ascenta Capital, and others.

More on SiliconCanals →


Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs